Familial Occurrence of Nonmedullary Thyroid Cancer: A Population-based Study of 5673 First-Degree Relatives of Thyroid Cancer Patients from Norway
The purpose of this study was to estimate the occurrence of familial nonmedullary thyroid cancer (FNMTC) in a large population-based study. Of the 5274 cases of thyroid cancer on record in the Norwegian Cancer Registry between 1960 and 1995, a total of 1025 patients could be identified with verified...
Gespeichert in:
Veröffentlicht in: | Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2001-02, Vol.10 (2), p.113-117 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The purpose of this study was to estimate the occurrence of familial
nonmedullary thyroid cancer (FNMTC) in a large population-based study.
Of the 5274 cases of thyroid cancer on record in the Norwegian Cancer
Registry between 1960 and 1995, a total of 1025 patients could be
identified with verified thyroid cancer, a unique personal
identification number, and a link to at least one parent. For patients
with nonmedullary carcinoma, 5457 first-degree relatives in 970
families were found, compared with 216 first-degree relatives in 37
families for the medullary cancers. A standardized incidence ratio
(SIR) was calculated among the relatives based on rates from the Cancer
Registry of Norway. A significantly increased risk of thyroid cancer
was found among the 5457 relatives of nonmedullary index cases, both
for males [SIR, 5.2; confidence interval (CI), 2.1–10.7; 7 cases]
and females (SIR, 4.9; CI, 3.0–7.7; 19 cases). All of these 26 thyroid
cancer cases were of the nonmedullary type. Furthermore, an increased
risk was found among 4282 relatives of papillary index cases, for both
males (SIR, 5.8; CI, 2.1–12.6; 6 cases) and females (SIR, 4.0; CI,
2.1–7.1; 12 cases). The 36 familial papillary thyroid cancer patients
had an average age at diagnosis of 43 years. Genetic influence is
probably only modest for the familial nonmedullary cases and clearly
weaker than for the classic familial type of medullary thyroid cancer. |
---|---|
ISSN: | 1055-9965 1538-7755 |